Patent ID: 8609093

Claim:
A method of treating an autoimmune disease or inflammatory disorder, the method comprising administering an effective amount of an anti-IL-17F antibody, or an antigen-binding fragment thereof, to a subject in need thereof, wherein said antibody, or antigen-binding fragment thereof, comprises: (a) a V H CDR1 region comprising the amino acid sequence of SEQ ID NO: 45; (b) a V H CDR2 region comprising the amino acid sequence of SEQ ID NO: 46; (c) a V H CDR3 region comprising the amino acid sequence of SEQ ID NO: 47; (d) a V L CDR1 region comprising the amino acid sequence of SEQ ID NO: 74; (e) a V L CDR2 region comprising the amino acid sequence of SEQ ID NO: 75; and (f) a V L CDR3 region comprising the amino acid sequence of SEQ ID NO: 76.